Medical sales is one of the highest-paying sales careers in the United States, but the headline numbers hide enormous variation. A tenured surgical device rep selling implants in a hospital operating room can earn more than double what a primary-care pharma rep earns in the same metro area. This guide breaks down what medical sales representatives actually earn in 2026, how compensation differs across pharma, medical device, biotech, and diagnostics, and what reps and hiring managers should expect at each level. For the broader context on how on-target earnings work in any sales role, see the pillar guide on On Target Earnings, and for cross-industry compensation benchmark data, see the sales compensation benchmarks guide.

Average Medical Sales Salary in 2026

Industry surveys from MedReps, the largest medical sales career site, place average annual compensation for tenured medical sales reps in the United States around $155,000 to $200,000 heading into 2026, depending on tenure, segment, survey year, and respondent mix. That total typically breaks into a base salary in the $110,000 to $140,000 range and variable pay (commission plus bonus) of $50,000 to $80,000 at expected attainment. Two caveats apply. First, the spread above and below is wide, and a rep’s actual earnings depend heavily on the segment they work in. Second, MedReps numbers come from rep self-reports, which historically run higher than employer-reported actuals; treat the upper end of these ranges as aspirational rather than typical.

Public data from the Bureau of Labor Statistics on wholesale sales representatives in technical and scientific products, the BLS occupational category that includes medical and pharmaceutical sales, reports a median annual wage near $100,000 with the top ten percent earning close to $195,000. The BLS figure runs lower than MedReps because it aggregates a much broader range of technical sales occupations and does not isolate medical sales specialties in the way industry surveys do. The MedReps survey is the more useful benchmark for someone evaluating a specific offer within the industry; the BLS data is the more conservative anchor.

Salary by Specialty: Medical Device vs Pharma

The biggest single driver of pay in medical sales is which subsegment a rep works in. Specialty surgical devices and high-value implant categories sit at the top of the range, generic pharma and basic primary-care reps sit at the bottom, and most other roles fall somewhere in between.

Surgical devices, particularly cardiovascular, orthopedic, and spine implants, can produce total compensation packages from $220,000 to $300,000 or more for tenured reps in established territories (in this guide, tenured means at least three to five years in the segment). Newer reps and reps in less-developed territories earn meaningfully less. These reps often attend procedures in the operating room and carry quotas measured in millions of dollars of implants per year. The base is typically in the $130,000 to $170,000 range, with variable pay tied directly to procedure volume and case coverage.

Capital medical equipment, including imaging, diagnostics, and lab systems, ranges from $160,000 to $230,000 total. Quotas are smaller in unit terms but each transaction is larger, so commission structures often resemble enterprise SaaS more than transactional pharma.

Biotech and specialty pharma sit in a similar range to specialty devices, often $180,000 to $250,000 for experienced reps selling rare-disease or oncology therapies. The base salary is usually higher than device roles to compensate for the longer sales cycles involved in formulary access (getting on the lists of medications insurers will cover) and reimbursement.

Primary-care pharmaceutical sales sits well below the device and specialty pharma tiers. Average total compensation runs $110,000 to $150,000, with a heavy base salary (often 80/20 or 75/25 pay mix) reflecting that primary-care reps detail physicians (the industry term for in-person product education visits) on lifestyle medications rather than closing high-value deals. Generic pharma and distributor roles sit lower still.

Entry-Level Earnings and Ramp Time

The averages above describe tenured reps with three or more years of segment experience. New entrants earn substantially less while they build clinical knowledge and territory relationships. First-year base salary for a new pharma rep typically runs $60,000 to $90,000 with $20,000 to $40,000 in variable pay at expected attainment, producing first-year total comp around $80,000 to $130,000. New medical device reps land a bit higher, with first-year base of $80,000 to $120,000 and total first-year comp of $100,000 to $150,000.

Ramp time varies by segment. Pharma reps often reach full productivity within the first year, though specialty segments may take longer. Medical device reps typically need 18 to 24 months to learn the clinical applications, build operating-room comfort, and develop hospital relationships. Surgical specialty reps may need 24 to 36 months to reach the full earning potential of an established territory. Most segments require a 4-year degree, and many device and surgical roles prefer candidates with prior medical, military, or B2B sales backgrounds.

Quota attainment in medical sales tends to run higher than the lower attainment rates commonly reported in many B2B SaaS organizations, because hospital and physician purchasing cycles are more predictable than software buying. Even so, posted OTE figures assume full attainment; treating them as guaranteed take-home overstates what most reps actually earn in any given year.

Base Salary, Variable Pay, and OTE Structure

Medical sales compensation follows the same base-plus-variable architecture as any other B2B sales role, but the pay mix tends to be more conservative than software sales. Many medical sales roles operate around a 70/30 or 75/25 base-to-variable split, though device and capital-equipment roles often skew more variable, and primary-care pharma skews more salary-heavy. The overall tilt toward base salary, relative to the 50/50 mix typical in B2B SaaS, reflects two structural realities. First, the sales cycle is longer; revenue lags the rep’s effort by months or quarters, particularly in device and biotech. Second, the role involves significant non-selling activities (clinical support, case coverage, regulatory training) that reps do regardless of whether deals close that month.

Surgical device roles run more variable, often 60/40, because rep behavior in the operating room directly influences purchasing decisions. Capital equipment reps land closer to 50/50 for the same reason. Pharma reps in non-specialty segments often see 80/20 or 85/15 mixes because detailing activity, not deal-closing, is what they are paid to do.

At-target earnings (OTE) for a mid-tenure medical sales rep cluster around $170,000 to $200,000 across most segments, with surgical specialties reaching $250,000 to $300,000 at full attainment and primary-care pharma sitting around $130,000 to $160,000. Above-quota performance carries meaningful upside in device and specialty segments because of accelerators on procedure volume or new-account activation.

OTE understates the total value of a medical sales package. Most employers also provide a company car or monthly car allowance, expense account for travel and customer meals, premium healthcare benefits, a 401(k) match, and structured training programs that can be worth $20,000 to $30,000 in market-rate equivalent for new hires. For reps in the field daily, the company car alone offsets a real personal expense. A medical sales package can offer significant additional value through benefits and field support programs that are less common in SaaS, though SaaS offers often include equity components (RSUs, ESPP, sign-on grants) that can rival or exceed those benefits at the right company and stage.

Commission Structures in Medical Sales

Medical sales uses several commission structures depending on the product type. The most common archetypes mirror what shows up elsewhere in B2B sales, with a few segment-specific quirks. For a broader catalog of pay structures, see the guide on sales commission structures.

Quota-based commission with accelerators is the most common structure for device and specialty pharma reps. The rep earns a flat commission rate up to quota, and an accelerated rate above quota, with above-quota multipliers typically running 1.5x to 2x base commission. Quota is set as an annual revenue or unit number and split across quarters.

Volume-based commission applies to many device and equipment reps, paying a flat percentage of bookings or procedures. The rep earns the same rate on every dollar regardless of attainment, which is simpler administratively but rewards activity volume rather than stretch performance.

Salary-plus-bonus is the typical structure in primary-care pharma. The rep earns a fixed base plus quarterly or annual bonuses tied to activity metrics (call frequency, sample drops, prescription volume in territory) and MBOs (Management by Objectives, structured goals set with the manager). Direct per-deal commission is uncommon in this segment because individual deal attribution is fuzzy when the rep’s job is to influence prescribing behavior rather than close transactions.

Highest-Paying Medical Sales Roles

Within medical sales, six categories regularly produce the highest annual compensation. Cardiovascular and electrophysiology device reps, who work with implantable cardiac rhythm devices and structural heart products, can clear $300,000 at full attainment in established territories. Orthopedic implant reps selling spine and joint replacement systems sit in a similar range, where top performers in established territories can exceed $280,000.

Surgical robotics and minimally invasive systems reps, a category that has grown rapidly since 2020, often pay enterprise-software-level OTEs of $230,000 to $300,000 because the products carry high six-figure capital prices and long sales cycles. Oncology specialty pharma, particularly oral oncolytics and infused therapies, lands in the $200,000 to $260,000 range driven by the rare-disease pricing premium.

Rare disease and gene therapy reps occupy the most extreme tier, where territory sizes are small (sometimes a dozen target physicians) but the products carry six- or seven-figure annual prices per patient. Compensation in this segment can exceed $300,000 for experienced reps. Medical device sales management, including regional and area director roles, regularly produces $250,000 to $400,000+ when overrides on team performance are included.

How Medical Sales Reps Increase Earnings

Three patterns reliably move a medical sales rep into a higher earnings band. First, segment migration. The single highest-leverage move is from primary-care pharma or generics into specialty pharma or device sales, where total compensation can increase significantly, often by 50 percent or more. The transition requires building clinical depth and territory references, but the payoff is substantial.

Second, tenure and territory quality. Medical sales rewards consistency. Reps who stay in a segment for three to five years and inherit established territories with strong customer relationships outearn reps who change companies frequently or work undeveloped territories. Territory quality is often more important than headline quota in determining take-home pay.

Third, management progression. Moving from individual contributor to first-line sales management, then to regional or area director, increases base salary and adds overrides on team performance. The trade-off is less direct selling and more administrative work; the financial upside is significant in device and specialty segments where team overrides can rival a strong IC year.

Reps evaluating offers should compare not just the OTE number, but the pay mix, the realism of the quota, the strength of the territory, and the commission structure underneath. A $180,000 OTE on a 70/30 mix with realistic quota and accelerators frequently outperforms a $220,000 OTE on a 50/50 mix with a stretched quota and no accelerators. For the math underneath those comparisons, see how to calculate sales commission.

The Bottom Line

Medical sales is among the best-paying B2B sales careers in the United States, with total compensation regularly clearing $200,000 for experienced reps and the top specialty tiers reaching $300,000 or more. The career rewards specialization: reps who build deep expertise in a high-value clinical category outearn generalists by significant multiples. Reps weighing an offer should look past the headline OTE to the underlying base, mix, quota, and territory quality, which together determine what the rep actually takes home.

Medical Sales Salary FAQ

How much do medical sales reps make?

Tenured medical sales reps in the United States typically earn well into six figures, with industry surveys placing average total compensation around $155,000 to $200,000 across segments. Newer reps earn substantially less during their first one to three years; specialty surgical, biotech, and rare-disease reps in established territories can earn well over $250,000.

Is medical sales a good career?

For reps with the right disposition, yes. The earnings ceiling is higher than most B2B sales careers outside top-tier enterprise software, the work involves real clinical learning, and tenured reps often have stable territories and long customer relationships. The trade-offs are demanding travel, slow ramp time (especially in device), and significant non-selling responsibilities such as case coverage and clinical support.

What is the highest-paying medical sales job?

Cardiovascular and electrophysiology device sales, surgical robotics sales, orthopedic and spine implant sales, and rare-disease specialty pharma consistently sit at the top of the earnings distribution. Sales management roles in these segments add another tier of upside through team overrides. The highest-earning individual contributors typically work in established territories with mature customer relationships.

Can medical sales reps earn over $300,000?

Yes, in the top-paying segments. Tenured reps in cardiovascular, surgical robotics, and rare-disease specialty roles can clear $300,000 in established territories at strong attainment. The figure is achievable, not typical; it represents a top tier of the career rather than an industry average.

What is the entry-level medical sales salary?

Entry-level pharma reps typically earn $80,000 to $130,000 total in year one, with base salary of $60,000 to $90,000 and variable pay of $20,000 to $40,000 at expected attainment. Entry-level medical device reps land higher, with first-year total compensation of $100,000 to $150,000. Earnings grow significantly with tenure and segment migration.

Salary figures in this guide are illustrative ranges based on industry surveys and public benchmarks; actual compensation varies by employer, region, segment, tenure, and individual performance. These figures describe W-2 employee compensation in the United States; 1099 distributor and independent rep arrangements follow different structures.